---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-034579"
form_type: "8-K"
ticker: "APGE"
cik: "0001974640"
company_name: "Apogee Therapeutics, Inc."
filed_at: "2026-03-25T23:59:59+00:00"
generated_at: "2026-05-15T09:05:40.348983+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Apogee Therapeutics prices public offering of 5M shares at $70, net ~$377.4M

## Summary
- 5,000,000 shares offered at $70 per share; underwriters' option for 750,000 shares exercised in full.
- Net proceeds expected ~$377.4M after underwriting discounts and commissions and estimated expenses.
- Offering expected to close March 26, 2026; underwriters include Jefferies, TD Securities, Stifel, Guggenheim.
- Shares sold under shelf registration statement (File No. 333-281503) effective August 12, 2024.

## SEC filing metadata
- accession: 0001104659-26-034579
- form_type: 8-K
- ticker: APGE
- cik: 0001974640
- company_name: Apogee Therapeutics, Inc.
- filed_at: 2026-03-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1974640/000110465926034579/0001104659-26-034579-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1974640/000110465926034579/tm269761d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-034579
- JSON: https://secwatch.observer/filing/0001104659-26-034579.json
- Plain text: https://secwatch.observer/filing/0001104659-26-034579.txt

## Key facts
- Material Agreements
  Apogee Therapeutics, Inc. entered into Underwriting Agreement with Jefferies LLC, TD Securities (USA) LLC, Stifel, Nicolaus & Company, Incorporated and Guggenheim Securities, LLC valued at $70.00 per share (effective 2026-03-24).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Jefferies LLC, TD Securities (USA) LLC, Stifel, Nicolaus & Company, Incorporated and Guggenheim Securities, LLC
  - Value: $70.00 per share
  - Effective: 2026-03-24
  source text: On March 24, 2026, Apogee Therapeutics, Inc. (the “Company”) entered into an underwriting agreement (“Underwriting Agreement”) with Jefferies LLC, TD Securities (USA) LLC, Stifel, Nicolaus & Company, Incorporated and Guggenheim Securities, LLC, as the representatives of the Underwriters named therein (the “Underwriters”), to issue and sell 5,000,000 shares of the Company’s common stock at a public offering price of $70.00 per share (the “Offering”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1974640/000110465926034579/0001104659-26-034579-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.